Viropharma Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Viropharma Inc (VPHM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Viropharma Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 550M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-17.8% annualized vs trailing 12 months).
- Peer revenue share: Viropharma Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
VPHM Sales vs. its Competitors, 2013
Viropharma Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Biotechnology & Pharmaceuticals industry grew revenue 21.1% year over year, combined, vs 24.2% for Viropharma Inc. Viropharma Inc's share of combined industry revenue moved from 0.25% to 0.26%, a gain of 0.01 percentage points.